BATS | ETF
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole.
The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| VERV | Verve Therapeutics Inc | Healthcare | Biotechnology | 5.08% |
| GPCR | Structure Therapeutics Inc. American Depositary Shares | Healthcare | Biotechnology | 3.17% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.98% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.89% |
| STOK | Stoke Therapeutics Inc | Healthcare | Biotechnology | 2.67% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 2.67% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.63% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 2.55% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 2.31% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 2.29% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 2.28% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 2.18% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 2.14% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 2.13% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 2.11% |
| RGNX | Regenxbio Inc | Healthcare | Biotechnology | 2.08% |
| 0QIU | Novo Nordisk A/S Class B | 2.04% | ||
| NSIS-B | Novonesis (Novozymes) A/S | Basic Materials | Specialty Chemicals | 1.96% |
| IMNM | Immunome Inc | Healthcare | Biotechnology | 1.75% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.72% |